Skip to product information
1 of 1

SURGE Pept

CJC-1295 (no Dac) 10mg

CJC-1295 (no Dac) 10mg

Regular price €54,95 EUR
Regular price Sale price €54,95 EUR
Sale Sold out
Taxes included.Shipping calculated at checkout.
Quantity

CJC-1295 without DAC 10mg — Research Material

CJC-1295 without DAC, commonly marketed as Modified GRF (1-29), is a synthetic peptide analog derived from the N-terminal region of human growth hormone-releasing hormone, also known as GHRH or GRF.

The compound is studied in controlled laboratory environments for its interaction with the GHRH receptor and for receptor-mediated signaling pathways associated with adenylate cyclase, cyclic AMP, protein kinase A, and downstream biochemical activity.

Unlike CJC-1295 with DAC, this research material does not contain the Drug Affinity Complex modification designed to facilitate prolonged albumin binding. It is therefore investigated separately as a shorter-duration GHRH-receptor research analog.

DAC versus non-DAC research analogs

CJC-1295 with DAC

CJC-1295 with DAC contains an albumin-binding modification intended to alter its pharmacokinetic characteristics and extend its persistence in experimental systems.

CJC-1295 without DAC / Modified GRF (1-29)

The non-DAC form does not contain the albumin-binding Drug Affinity Complex. Laboratory investigations have examined its peptide stability, receptor interaction, signaling profile, and comparatively shorter experimental activity.

The commercial names CJC-1295 without DAC and Modified GRF (1-29) are often used interchangeably. However, naming practices can vary between suppliers, and the identity, purity, salt form, and composition of a research material should be confirmed through appropriate analytical documentation.

References to muscle growth, fat reduction, wound healing, bone strengthening, metabolic improvement, dosing frequency, or other physiological outcomes have been omitted because such wording may imply intended human use or therapeutic efficacy. FDA has specifically evaluated CJC-1295-related substances in the context of pharmaceutical compounding and has identified safety concerns and limited clinical information.

Research Use Only

FOR LABORATORY RESEARCH USE ONLY.

For use only by qualified laboratory professionals in controlled research environments.

Not for human or veterinary use.
Not for human consumption.
Not intended for injection, ingestion, inhalation, topical application, or administration to humans or animals.

Not intended for clinical, diagnostic, therapeutic, preventive, nutritional, cosmetic, body-composition, athletic-performance, or household use.

Not intended for pharmaceutical compounding or for the preparation of any product intended for human or animal administration.

This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition, nor is it intended to affect the structure or function of the human or animal body.

This product has not been evaluated or approved by the U.S. Food and Drug Administration.

Handle, store, and dispose of this material in accordance with applicable laboratory safety procedures and all relevant federal, state, and local requirements.

View full details

Laboratory analysis

Batch SP-CJCN-2608A
Chromatogram · illustration METHOD HPLC-UV 214nm · the measured curve for batch SP-CJCN-2608A is in its certificate
main peak imp. imp. 02 46 8 min
≥99%
Release criterion
Independent laboratory
Tested before listing
Tied to your batch code
Full chromatogram on request
Verify this batch
Batch
SP-CJCN-2608A
Method
HPLC-UV 214nm
Purity
≥99%
Form
Lyophilized
Availability
In stock
The Growth Stack
✶ Also in a stack

Growth Stack

This compound is part of a curated protocol. The stack works out cheaper than the vials separately — and ships with free BAC Water.

€209,80€159,95
View stack
CJC-1295 (no Dac) 10mg
€54,95